These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 29386223)

  • 1. Is the provision of paediatric oral liquid unlicensed medicines safe?
    Rawlence E; Lowey A; Tomlin S; Auyeung V
    Arch Dis Child Educ Pract Ed; 2018 Dec; 103(6):310-313. PubMed ID: 29386223
    [No Abstract]   [Full Text] [Related]  

  • 2. Adverse drug reactions to unlicensed and off-label drugs on paediatric wards: a prospective study.
    Turner S; Nunn AJ; Fielding K; Choonara I
    Acta Paediatr; 1999 Sep; 88(9):965-8. PubMed ID: 10519338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pediatric Off-Label and Unlicensed Drug Use and Its Implications.
    Gore R; Chugh PK; Tripathi CD; Lhamo Y; Gautam S
    Curr Clin Pharmacol; 2017; 12(1):18-25. PubMed ID: 28322168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of unlicensed and off-label drug use on adverse drug reactions in paediatric patients.
    Neubert A; Dormann H; Weiss J; Egger T; Criegee-Rieck M; Rascher W; Brune K; Hinz B
    Drug Saf; 2004; 27(13):1059-67. PubMed ID: 15471510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Essential Medicines for Children.
    Hoppu K
    Clin Pharmacol Ther; 2017 Jun; 101(6):718-720. PubMed ID: 28182281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drugs for Children.
    Ito S
    Clin Pharmacol Ther; 2017 Jun; 101(6):704-706. PubMed ID: 28510298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of unlicensed and off-label medications in paediatric gastroenterology with a review of the commonly used formularies in the UK.
    Dick A; Keady S; Mohamed F; Brayley S; Thomson M; Lloyd BW; Heuschkel R; Afzal NA
    Aliment Pharmacol Ther; 2003 Feb; 17(4):571-5. PubMed ID: 12622766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medicines management: an interview study of nurses at a secure psychiatric hospital.
    Haw C; Stubbs J; Dickens G
    J Adv Nurs; 2015 Feb; 71(2):281-94. PubMed ID: 25082212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Off-label and unlicensed medicines to hospitalised children in Norway.
    Teigen A; Wang S; Truong BT; Bjerknes K
    J Pharm Pharmacol; 2017 Apr; 69(4):432-438. PubMed ID: 27334565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Off-label and unlicensed utilisation of medicines in a French paediatric hospital.
    Joret-Descout P; Prot-Labarthe S; Brion F; Bataille J; Hartmann JF; Bourdon O
    Int J Clin Pharm; 2015 Dec; 37(6):1222-7. PubMed ID: 26394784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review of the processes for FDA oversight of drugs, medical devices, and combination products.
    Sweet BV; Schwemm AK; Parsons DM
    J Manag Care Pharm; 2011; 17(1):40-50. PubMed ID: 21204589
    [No Abstract]   [Full Text] [Related]  

  • 12. Paediatric medicines research in the UK: how to move forward?
    Wong I; Sweis D; Cope J; Florence A
    Drug Saf; 2003; 26(8):529-37. PubMed ID: 12825967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paediatric clinical pharmacology: at the beginning of a new era.
    Hoppu K
    Eur J Clin Pharmacol; 2008 Feb; 64(2):201-5. PubMed ID: 17972069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse Drug Reactions in Children: The Double-Edged Sword of Therapeutics.
    Elzagallaai AA; Greff M; Rieder MJ
    Clin Pharmacol Ther; 2017 Jun; 101(6):725-735. PubMed ID: 28295234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prescribing for off-label use and unauthorized medicines in three paediatric wards in Finland, the status before and after the European Union Paediatric Regulation.
    Lindell-Osuagwu L; Hakkarainen M; Sepponen K; Vainio K; Naaranlahti T; Kokki H
    J Clin Pharm Ther; 2014 Apr; 39(2):144-53. PubMed ID: 24329556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Off-Label Medication in Children: Responsibilities of Pediatrician and Neonatologist.
    Das JC; Hossain MA; Shahidullah M; Mannan MA
    Mymensingh Med J; 2018 Oct; 27(4):912-916. PubMed ID: 30487515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of medicines delivered by homecare companies.
    Matthews A; Donaldson LJ; Evans SJ; Langan SM
    BMJ; 2018 May; 361():k2201. PubMed ID: 29789283
    [No Abstract]   [Full Text] [Related]  

  • 18. Supply problems of unlicensed and off-label medicines after discharge.
    Wong IC; Basra N; Yeung VW; Cope J
    Arch Dis Child; 2006 Aug; 91(8):686-8. PubMed ID: 16717083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unlicensed and off-label drug use in children: implications for safety.
    Choonara I; Conroy S
    Drug Saf; 2002; 25(1):1-5. PubMed ID: 11820908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unlicensed pharmaceutical preparations for clinical patient care: Ensuring safety.
    de Wilde S; de Jong MGH; Le Brun PPH; Guchelaar HJ; Schimmel KJM
    Pharmacoepidemiol Drug Saf; 2018 Jan; 27(1):3-8. PubMed ID: 29047193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.